Phase II clinical trial of 4?-O-Tetrahydropyranyl-Adriamycin (THP-Adriamycin) in recurrent squamous cell carcinoma of the head and neck

Investigational New Drugs ◽

10.1007/bf00194554 ◽

1991 ◽

Vol 9 (1) ◽

Author(s):

DongM. Shin ◽

AlanM. Kramer ◽

IsaiahW. Dimery ◽

MartinN. Raber ◽

Michael Ewer ◽

...

Keyword(s):

Clinical Trial ◽

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Head And Neck ◽

Phase Ii ◽

Squamous Cell ◽

Phase Ii Clinical Trial ◽

Recurrent Squamous Cell Carcinoma

Download Full-text

A phase II study of combination chemotherapy with capecitabine and cisplatin in patients with metastatic or recurrent squamous cell carcinoma of the head and neck

Annals of Oncology ◽

10.1093/annonc/mdq355 ◽

2011 ◽

Vol 22 (2) ◽

pp. 417-423 ◽

Author(s):

Y.-W. Won ◽

Y.H. Park ◽

M.J. Ahn ◽

I.-G. Do ◽

Y.H. Ko ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Head And Neck ◽

Phase Ii ◽

Squamous Cell ◽

Combination Chemotherapy ◽

Phase Ii Study ◽

Recurrent Squamous Cell Carcinoma

Download Full-text

A phase II trial of 10-Ethyl-10-deaza-aminopterin, a novel antifolate, in patients with advanced and/or recurrent squamous cell carcinoma of the head and neck

Annals of Oncology ◽

10.1093/oxfordjournals.annonc.a058156 ◽

1992 ◽

Vol 3 (3) ◽

pp. 223-226 ◽

Author(s):

J.H. Schornagel ◽

J. Verweij ◽

P.H.M. de Mulder ◽

F. Cognetti ◽

J.B. Vermorken ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Head And Neck ◽

Phase Ii ◽

Squamous Cell ◽

Phase Ii Trial ◽

Recurrent Squamous Cell Carcinoma

Download Full-text

Phase II Trial of a Paclitaxel-Carboplatin Combination in Recurrent Squamous Cell Carcinoma of the Head and Neck

Oncology ◽

10.1159/000055299 ◽

2000 ◽

Vol 60 (1) ◽

pp. 66-71 ◽

Author(s):

X. Pivot ◽

L. Cals ◽

D. Cupissol ◽

E. Guardiola ◽

X. Tchiknavorian ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Head And Neck ◽

Phase Ii ◽

Squamous Cell ◽

Phase Ii Trial ◽

Recurrent Squamous Cell Carcinoma

Download Full-text

1087P Time to clinically meaningful changes in pain in patients with advanced cutaneous squamous cell carcinoma treated with cemiplimab in a phase II clinical trial

Annals of Oncology ◽

10.1016/j.annonc.2020.08.1211 ◽

2020 ◽

Vol 31 ◽

pp. S738

Author(s):

M.R. Migden ◽

D. Rischin ◽

S. Hudgens ◽

C-I. Chen ◽

C.D. Schmults ◽

...

Keyword(s):

Clinical Trial ◽

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Phase Ii ◽

Squamous Cell ◽

Cutaneous Squamous Cell Carcinoma ◽

Phase Ii Clinical Trial

Download Full-text

A Phase II Study of Ifosfamide in Recurrent Squamous Cell Carcinoma of the Head and Neck

American Journal of Clinical Oncology ◽

10.1097/00000421-199608000-00012 ◽

1996 ◽

Vol 19 (4) ◽

pp. 379-383 ◽

Author(s):

Martin H. Huber ◽

Scott M. Lippman ◽

Steven E. Benner ◽

Mihran Shirinian ◽

Isaiah W. Dimery ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Head And Neck ◽

Phase Ii ◽

Squamous Cell ◽

Phase Ii Study ◽

Recurrent Squamous Cell Carcinoma

Download Full-text

A phase II evaluation of a 3-hour infusion of paclitaxel, cisplatin, and 5-fluorouracil in patients with advanced or recurrent squamous cell carcinoma of the head and neck

Cancer ◽

10.1002/cncr.21994 ◽

2006 ◽

Vol 107 (2) ◽

pp. 319-327 ◽

Author(s):

Francis P. Worden ◽

James Moon ◽

Wolfram Samlowski ◽

Joseph I. Clark ◽

Shaker R. Dakhil ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Head And Neck ◽

Phase Ii ◽

Squamous Cell ◽

Recurrent Squamous Cell Carcinoma

Download Full-text

A randomized, phase II study of afatinib versus cetuximab in metastatic or recurrent squamous cell carcinoma of the head and neck

Annals of Oncology ◽

10.1093/annonc/mdu216 ◽

2014 ◽

Vol 25 (9) ◽

pp. 1813-1820 ◽

Author(s):

T.Y. Seiwert ◽

J. Fayette ◽

D. Cupissol ◽

J.M. del Campo ◽

P.M. Clement ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Head And Neck ◽

Phase Ii ◽

Squamous Cell ◽

Phase Ii Study ◽

Randomized Phase Ii ◽

Recurrent Squamous Cell Carcinoma

Download Full-text

Human papillomavirus (HPV) infection as a prognostic factor in patients with oropharyngeal squamous cell carcinoma treated in a prospective phase II clinical trial

Journal of Clinical Oncology ◽

10.1200/jco.2008.26.15_suppl.6035 ◽

2008 ◽

Vol 26 (15_suppl) ◽

pp. 6035-6035 ◽

Author(s):

S. Jo ◽

A. Juhasz ◽

K. Zhang ◽

C. Ruel ◽

S. P. Wilczynski ◽

...

Keyword(s):

Clinical Trial ◽

Squamous Cell Carcinoma ◽

Human Papillomavirus ◽

Prognostic Factor ◽

Cell Carcinoma ◽

Phase Ii ◽

Squamous Cell ◽

Hpv Infection ◽

Phase Ii Clinical Trial ◽

Prospective Phase

Download Full-text

Abstract C22: A phase II study of intravenous wild-type reovirus (Reolysin®) in combination with paclitaxel plus carboplatin in patients with platinum refractory metastatic and/or recurrent squamous cell carcinoma of the head and neck.

10.1158/1535-7163.targ-11-c22 ◽

2011 ◽

Author(s):

Anand B. Karnad ◽

Missak Haigentz ◽

Tracy Miley ◽

Matt Coffey ◽

George Gill ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Head And Neck ◽

Phase Ii ◽

Squamous Cell ◽

Phase Ii Study ◽

Wild Type ◽

Recurrent Squamous Cell Carcinoma ◽

Platinum Refractory

Download Full-text

Abstract PR01: Genomic and functional correlates from a phase II clinical trial of trametinib in surgically resectable oral cavity squamous cell carcinoma

10.1158/1557-3265.aacrahns17-pr01 ◽

2017 ◽

Author(s):

Paul A. Zolkind ◽

Katie M. Campbell ◽

Tianxiang Lin ◽

Zach Skidmore ◽

Ashley Winkler ◽

...

Keyword(s):

Clinical Trial ◽

Squamous Cell Carcinoma ◽

Oral Cavity ◽

Cell Carcinoma ◽

Phase Ii ◽

Squamous Cell ◽

Phase Ii Clinical Trial

Download Full-text